| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.9M | +85.3% |
| Cost of Revenue | $666K | -51.8% |
| Gross Profit | $1.2M | +412.2% |
| R&D Expense | $147K | — |
| SG&A Expense | $4.2M | +99.4% |
| Operating Income | -$3.8M | +18.3% |
| Pre-tax Income | -$2.4M | +43.4% |
| Income Tax | -$82K | -124.4% |
| Net Income | -$5.1M | -12.4% |
| EPS (Basic) | -$0.08 | -14.3% |
| EPS (Diluted) | -$0.08 | -14.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.8M | +41.4% |
| Short-term Investments | $2.2M | +134.3% |
| Accounts Receivable | $300K | — |
| Current Assets | $45.2M | +50.5% |
| Total Assets | $46.6M | +30.6% |
| Current Liabilities | $1.8M | -84.8% |
| Total Liabilities | $2.6M | -77.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.4M | +32.6% |
| Capital Expenditures | $3K | +0.0% |
| Investing Cash Flow | -$1.2M | -130.9% |
| Financing Cash Flow | $13.4M | +76.7% |
| Free Cash Flow | -$2.4M | +32.6% |
| $44.0M |
| +82.8% |